Synthesis and anticancer and cytotoxic effects of novel 1,4-phenylene-bis-N-thiocarbamoylpyrazole and 1,4-phenylene-bis-pyrazolylthiazole derivatives      
Yazarlar (5)
Prof. Dr. Meliha Burcu GÜRDERE Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Erdoğan Kamo
Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Prof. Dr. Yakup BUDAK Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Ayşe Şahin Yağlıoğlu
Çankırı Karatekin Üniversitesi, Türkiye
Prof. Dr. Mustafa CEYLAN Tokat Gaziosmanpaşa Üniversitesi, Türkiye
Makale Türü Özgün Makale
Makale Alt Türü SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale
Dergi Adı Turkish Journal of Chemistry
Dergi ISSN 1300-0527 Wos Dergi Scopus Dergi
Dergi Tarandığı Indeksler SCI-Expanded
Dergi Grubu Q4
Makale Dili İngilizce
Basım Tarihi 01-2017
Cilt No 41
Sayı 2
Sayfalar 179 / 189
DOI Numarası 10.3906/kim-1604-84
Makale Linki http://online.journals.tubitak.gov.tr/openDoiPdf.htm?mKodu=kim-1604-84
Özet
Thiazolylpyrazoline derivatives were recently reported as potent anticancer agents. In this study, novel 1,4-phenylene-bis-N-thiocarbamoylpyrazoles (3a h) and 1,4-phenylene-bis-pyrazolylthiazoles (5a h) were prepared and screened for their anticancer activities against C6 (rat brain tumor cells) and HeLa (human uterus carcinoma). Anticancer activity studies were performed as a dose-dependent assay starting with eight concentrations. 5-Fluorouracil (5-FU) was used as a positive control. Compounds 3c, 3d, and 3h were examined and they revealed almost the same activities compared with 5-FU in terms of cell selectivity against C6 cells. Moreover, compounds 3a h had lower cytotoxicity than 5-FU. The low cytotoxicity values of 3a h as well as their high antiproliferative activity were encouraging, but further studies are required on the use of these molecules as anticancer drugs.
Anahtar Kelimeler
Bis-chalcone | bis-N-thiocarbamoylpyrazole | bis-pyrazolylthiazole | HeLa | C6 | anticancer activity | cytotoxicity